Copolymer nanoparticles composed of sulfobetaine and poly(ε-caprolactone) as novel anticancer drug carriers

Journal of Biomedical Materials Research. Part a
Jun CaoXiang-Lin Luo

Abstract

Novel ABA type amphiphilic copolymers (PCL-APS-PCL) consisting of polycaprolactone (PCL) (A) as hydrophobic block and N,N'-bis (2-hydroxyethyl) methylamine ammonium propane sulfonate (APS) (B) as hydrophilic segment, self-assembled into nanoparticles (NPs) with solvent evaporation method. The sizes and size distributions of NPs were characterized by dynamic light scattering. The morphology of NPs was observed by scanning electron microscopy (SEM). The critical micelle concentration (CMC) was determined by fluorescent probe. The drug loading content (DLC) and the drug release amount were characterized by UV-visible spectrophotometer. The cytotoxicity of the NPs was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-trazoliumbromide (MTT) assay. It was found that the NPs were spherical in shape with sizes around 100 nm. The CMCs of the copolymers were quite low (×10(-4) mg/mL). The DLC decreased with lengthening of hydrophobic PCL block. In vitro drug release experiment demonstrated that the release rate of paclitaxel sped with the decrease of PCL length. MTT results showed that NPs were nontoxic to osteoblast and human epithelial carcinoma (hela) cells. After drug loading, NPs could restrain the growth of hela or even kill ...Continue Reading

References

Jan 19, 1999·Pharmaceutical Research·A MiwaH Kawahara
Jul 9, 1999·Journal of Biomedical Materials Research·M F ZambauxC Vigneron
Jan 21, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·P CrosassoL Cattel
Dec 18, 2002·Journal of Biomaterials Science. Polymer Edition·Y L YuanS C Lin
Jan 16, 2003·International Journal of Pharmaceutics·Jong-Hoon LeeSung-Ho Kim
Mar 12, 2003·Advanced Drug Delivery Reviews·Hidenori OtsukaKazunori Kataoka
May 8, 2003·Journal of Biomedical Materials Research. Part a·Tomohiro KonnoKazuhiko Ishihara
May 8, 2003·Journal of Biomedical Materials Research. Part a·Huang-Chien LiangHsing-Wen Sung
May 20, 2004·Bioconjugate Chemistry·Xintao ShuaiThomas Kissel
Aug 20, 2005·Journal of Biomedical Materials Research. Part a·E Pierri, K Avgoustakis
Sep 1, 2005·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·S Sajeesh, Chandra P Sharma
Jun 1, 2006·Journal of Biomedical Materials Research. Part a·Conroy SunMiqin Zhang
Jul 21, 2006·The Journal of Physical Chemistry. B·Yujun SongChalla S S R Kumar
Aug 17, 2006·Journal of Biomaterials Science. Polymer Edition·Leenaporn JongpaiboonkitJun Li
Oct 31, 2006·Journal of Biomedical Materials Research. Part a·Xuemei WangBaoan Chen
Jan 30, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jubo LiuChristine Allen
May 3, 2007·Journal of Biomaterials Science. Polymer Edition·Michael GoldbergXinqiao Jia
May 1, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hongtao ChenJi-Xin Cheng
May 19, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sofia Papadimitriou, Dimitrios Bikiaris
Mar 20, 2010·Journal of the American Chemical Society·Eleonora MuroBenoit Dubertret
Oct 15, 2010·Langmuir : the ACS Journal of Surfaces and Colloids·Zaki G EstephanJoseph B Schlenoff
Nov 26, 2010·Journal of Biomedical Materials Research. Part a·Chen ChenLiqun Wang
Apr 16, 2011·Journal of Biomedical Materials Research. Part a·Jun CaoXiang-Lin Luo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.